首页 | 本学科首页   官方微博 | 高级检索  
     


Computational redesign of the SHV-1 beta-lactamase/beta-lactamase inhibitor protein interface
Authors:Reynolds Kimberly A  Hanes Melinda S  Thomson Jodi M  Antczak Andrew J  Berger James M  Bonomo Robert A  Kirsch Jack F  Handel Tracy M
Affiliation:1 Biophysics Graduate Group, University of California, Berkeley, Berkeley, CA 94720, USA
2 Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, CA 92093-0684, USA
3 Louis Stokes Cleveland Department of Veterans Affairs Medical Center and the Department of Pharmacology, Case Western Reserve University, School of Medicine, Cleveland, OH 44106, USA
4 Department of Molecular and Cell Biology and QB3 Institute, University of California, Berkeley, Berkeley, CA 94720, USA
Abstract:
β-lactamases are enzymes that catalyze the hydrolysis of β-lactam antibiotics. β-lactamase/β-lactamase inhibitor protein (BLIP) complexes are emerging as a well characterized experimental model system for studying protein-protein interactions. BLIP is a 165 amino acid protein that inhibits several class A β-lactamases with a wide range of affinities: picomolar affinity for K1; nanomolar affinity for TEM-1, SME-1, and BlaI; but only micromolar affinity for SHV-1 β-lactamase. The large differences in affinity coupled with the availability of extensive mutagenesis data and high-resolution crystal structures for the TEM-1/BLIP and SHV-1/BLIP complexes make them attractive systems for the further development of computational design methodology. We used EGAD, a physics-based computational design program, to redesign BLIP in an attempt to increase affinity for SHV-1. Characterization of several of designs and point mutants revealed that in all cases, the mutations stabilize the interface by 10- to 1000-fold relative to wild type BLIP. The calculated changes in binding affinity for the mutants were within a mean absolute error of 0.87 kcal/mol from the experimental values, and comparison of the calculated and experimental values for a set of 30 SHV-1/BLIP complexes yielded a correlation coefficient of 0.77. Structures of the two complexes with the highest affinity, SHV-1/BLIP (E73M) and SHV-1/BLIP (E73M, S130K, S146M), are presented at 1.7 Å resolution. While the predicted structures have much in common with the experimentally determined structures, they do not coincide perfectly; in particular a salt bridge between SHV-1 D104 and BLIP K74 is observed in the experimental structures, but not in the predicted design conformations. This discrepancy highlights the difficulty of modeling salt bridge interactions with a protein design algorithm that approximates side chains as discrete rotamers. Nevertheless, while local structural features of the interface were sometimes miscalculated, EGAD is globally successful in designing complexes with increased affinity.
Keywords:BLIP, β-lactamase inhibitor protein   vdW, van der Waals   ncf, nitrocefin   DEE, dead-end elimination
本文献已被 ScienceDirect PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号